Cutaneous Melanoma Suspended Phase 2 Trials for Rasdegafusp alfa (DB15185)

IndicationStatusPhase
DBCOND0040978 (Cutaneous Melanoma)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02129075CDX-1401 and Poly-ICLC Vaccine Therapy With or Without CDX-301 in Treating Patients With Stage IIB-IV MelanomaTreatment